Medicine and Dentistry
Liver Disease
100%
Metabolic Dysfunction-Associated Steatotic Liver Disease
94%
Fibrosis
58%
Hepatology
57%
Nonalcoholic Fatty Liver
53%
Liver Cirrhosis
48%
Decompensated Liver Cirrhosis
32%
Systematic Review
31%
Randomized Controlled Trial
31%
Fatty Liver
29%
Hepatitis B
29%
Prevalence
28%
Liver Function
27%
Diseases
27%
Retrospective Study
25%
Liver Fibrosis
22%
Hepatitis C
21%
COVID-19
21%
Cohort Analysis
21%
Chronic Liver Disease
21%
Macrophage
21%
Metabolic Dysfunction-Associated Steatohepatitis
21%
Liver Transplantation
20%
Maturity Onset Diabetes of the Young
19%
Public Health
18%
Infection
16%
Physical Activity
15%
Disease Management
15%
Nutrition
15%
Alcohol-Related Liver Disease
15%
Model for End-Stage Liver Disease
15%
Clinical Trial
14%
Chronic Kidney Disease
14%
Ingestion
14%
Primary Health Care
13%
Medicine
13%
Frailty
12%
Diabetes
12%
Cohort Study
12%
Hepatocellular Carcinoma
12%
Specialist Care
12%
Alcohol Consumption
11%
Patient Referral
10%
Virus
10%
Odontoid Process Fracture
10%
Neuro-Oncology
10%
Subdural Hematoma
10%
Alanine Aminotransferase
10%
Dexamethasone
10%
Acute Liver Failure
10%
Keyphrases
Metabolic-associated Fatty Liver Disease (MAFLD)
94%
Non-alcoholic Fatty Liver Disease (NAFLD)
53%
Hepatology
51%
Liver Disease
50%
Liver
44%
Scotland
40%
Decompensated Cirrhosis
35%
Fibrosis
34%
Phosphoinositide 3-kinase (PI3K)
31%
Nonalcoholic Steatohepatitis
31%
Steatotic Liver Disease
31%
Liver Cirrhosis
31%
Cirrhosis
30%
Scottish
24%
T Cells
24%
British Association
22%
Older Adults
22%
Liver Function Tests
22%
Hepatitis C
21%
Fatty Liver Disease
21%
Multicenter Retrospective Study
21%
Hepatitis B
21%
Disease Management
21%
Randomized Controlled Trial
21%
MELD Score
21%
Macrophage Therapy
21%
Hepatocellular Carcinoma
20%
Interleukin-2
19%
Type 2 Diabetes Mellitus (T2DM)
18%
Etiology
16%
Chronic Kidney Disease
15%
Clinical Practice Guidelines
14%
Antifibrotic
14%
Advanced Liver Disease
13%
Liver Fibrosis
13%
Physical Activity
13%
Rapamycin
12%
Care Delivery
12%
Phase 2 Randomized Controlled Trial
12%
Phosphorylation
12%
British Society
12%
Specialty Care
12%
Narrative Review
12%
S6 Kinase 1 (S6K1)
11%
Soluble interleukin-2 Receptor (sIL-2R)
11%
Chronic Infection
11%
Diabetes
11%
Tayside
11%
Fibrosis Assessment
11%
Liver Transplantation
11%